<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04717609</url>
  </required_header>
  <id_info>
    <org_study_id>JHOR 20D.975</org_study_id>
    <nct_id>NCT04717609</nct_id>
  </id_info>
  <brief_title>Saphenous Nerve Block for Partial Meniscectomy</brief_title>
  <official_title>Surgeon Performed Saphenous Nerve Block at the Medial Femoral Condyle for Arthroscopic Partial Meniscectomy and Meniscus Repair: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Partial meniscectomy and meniscus repair are two of the most common orthopedic surgery&#xD;
      procedures. As these procedures are being increasingly performed in ambulatory surgical&#xD;
      centers, there has been a shift towards providing improved analgesia to ensure timely&#xD;
      discharge, as well as preventing unwanted pain and side effects. As such, it has become&#xD;
      common practice to use an intra-articular injection of local anesthetic to achieve&#xD;
      post-operative pain control. However, these effects are short lived, requiring a multimodal&#xD;
      approach to analgesia. To date, no optimal pain control strategy has been described for&#xD;
      arthroscopic partial meniscectomy or meniscus repair. The purpose of this study is to examine&#xD;
      the outcomes of subcutaneous saphenous nerve block with 0.5% ropivacaine at the medial&#xD;
      femoral epicondyle/adductor hiatus plus portal 0.5% ropivacaine injection vs portal 0.5%&#xD;
      ropivacaine injection alone for patients undergoing arthroscopic partial meniscectomy or&#xD;
      meniscus repair.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">January 25, 2021</start_date>
  <completion_date type="Anticipated">January 25, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 25, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduced Pain Levels</measure>
    <time_frame>10 days</time_frame>
    <description>This will be measured by Participant Opioid Use will be collected everyday for 10 days after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Recovery</measure>
    <time_frame>20 minutes</time_frame>
    <description>After surgery while in the recovery room a 40 question survey will be administered regarding your comfort level, emotional state and pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduced Pain Levels</measure>
    <time_frame>10 days</time_frame>
    <description>This will be measured using the numeric rating score (NRS). It will be collected at 1 and 10 days after surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Pain, Joint</condition>
  <condition>Pain, Procedural</condition>
  <condition>Meniscectomy</condition>
  <arm_group>
    <arm_group_label>Partial Meniscectomy without Saphenous Nerve Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants scheduled for partial meniscectomy will preoperatively receive 0.5% ropivacaine with epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Partial Meniscectomy with Saphenous Nerve Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants scheduled for a partial meniscectomy will preoperatively receive a saphenous nerve block at the medial femoral condyle in addition to an injection of 0.5% ropivacaine with epinephrine</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Saphenous Nerve Block</intervention_name>
    <description>Preoperative Saphenous Nerve Block for partial Meniscectomy</description>
    <arm_group_label>Partial Meniscectomy with Saphenous Nerve Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine injection</intervention_name>
    <description>preoperatively the participant will receive an injection ar the surgical site of 5 milliliters (mL) of 0.5% ropivacaine</description>
    <arm_group_label>Partial Meniscectomy with Saphenous Nerve Block</arm_group_label>
    <arm_group_label>Partial Meniscectomy without Saphenous Nerve Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥ 18&#xD;
&#xD;
          -  Scheduled for arthroscopic meniscectomy or meniscus repair&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Multiple-ligament injury&#xD;
&#xD;
          -  Primary ACL reconstruction or ACL revision reconstruction&#xD;
&#xD;
          -  Articular cartilage restoration surgery&#xD;
&#xD;
          -  Evidence of microfracture&#xD;
&#xD;
          -  History of allergy to local anesthetics&#xD;
&#xD;
          -  Pre-existing saphenous neuropathy&#xD;
&#xD;
          -  Unable to be prescribed opioids due to allergy or other reason&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rothman Orthopaedic Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 18, 2021</study_first_submitted>
  <study_first_submitted_qc>January 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>January 18, 2021</last_update_submitted>
  <last_update_submitted_qc>January 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthralgia</mesh_term>
    <mesh_term>Pain, Procedural</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

